Alerts will be sent to your verified email
Verify Email
JAGSNPHARM
|
Jagsonpal Pharma
|
Lincoln Pharma
|
Fredun Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
16.01 % | 15.1 % | 11.84 % |
|
5yr average Equity Multiplier
|
1.27 | 1.26 | 2.85 |
|
5yr Average Asset Turnover Ratio
|
1.09 | 0.82 | 1.08 |
|
5yr Avg Net Profit Margin
|
12.08 % | 14.59 % | 3.9 % |
|
Price to Book
|
5.17 | 1.87 | 8.28 |
|
P/E
|
33.14 | 15.23 | 39.83 |
|
5yr Avg Cash Conversion Cycle
|
2.39 Days | -6.41 Days | 175.29 Days |
|
Inventory Days
|
31.56 Days | 43.91 Days | 146.68 Days |
|
Days Receivable
|
15.63 Days | 91.75 Days | 142.46 Days |
|
Days Payable
|
59.94 Days | 128.38 Days | 112.95 Days |
|
5yr Average Interest Coverage Ratio
|
66.99 | 63.13 | 2.62 |
|
5yr Avg ROCE
|
18.99 % | 19.81 % | 22.71 % |
|
5yr Avg Operating Profit Margin
|
13.23 % | 18.35 % | 9.7 % |
|
5 yr average Debt to Equity
|
0.01 | 0.0 | 0.93 |
|
5yr CAGR Net Profit
|
26.54 % | 5.76 % | 25.5 % |
|
5yr Average Return on Assets
|
12.71 % | 11.92 % | 4.18 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
67.89 % | 49.78 % | 44.17 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.82 % | 2.78 % | -5.98 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Jagsonpal Pharma
|
Lincoln Pharma
|
Fredun Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|